ELV Quote, Financials, Valuation and Earnings

Centene has a net margin of 2.25% compared to Elevance Health's net margin of 1.7%. Elevance Health's return on equity of 15.67% beat Centene's return on equity of 11.5%.

Elevance Health has a consensus price target of $505.44, signalling upside risk potential of 36.21%. On the other hand Centene has an analysts' consensus of $79.39 which suggests that it could grow by 31.01%. Given that Elevance Health has higher upside potential than Centene, analysts believe Elevance Health is more attractive than Centene.

Elevance Health has a beta of 0.828, which suggesting that the stock is 17.228% less volatile than S&P 500. In comparison Centene has a beta of 0.457, suggesting its less volatile than the S&P 500 by 54.321%.

Elevance Health has a quarterly dividend of $1.63 per share corresponding to a yield of 1.76%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 23.3% of its earnings as a dividend. Centene pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health quarterly revenues are $45.1B, which are larger than Centene quarterly revenues of $42B. Elevance Health's net income of $1B is higher than Centene's net income of $713M. Notably, Elevance Health's price-to-earnings ratio is 13.53x while Centene's PE ratio is 10.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.50x versus 0.20x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare has a net margin of 2.25% compared to Elevance Health's net margin of 3.15%. Elevance Health's return on equity of 15.67% beat Molina Healthcare's return on equity of 25.77%.

Elevance Health has a consensus price target of $505.44, signalling upside risk potential of 36.21%. On the other hand Molina Healthcare has an analysts' consensus of $360.77 which suggests that it could grow by 22.64%. Given that Elevance Health has higher upside potential than Molina Healthcare, analysts believe Elevance Health is more attractive than Molina Healthcare.

Elevance Health has a beta of 0.828, which suggesting that the stock is 17.228% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.536, suggesting its less volatile than the S&P 500 by 46.386%.

Elevance Health has a quarterly dividend of $1.63 per share corresponding to a yield of 1.76%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 23.3% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health quarterly revenues are $45.1B, which are larger than Molina Healthcare quarterly revenues of $10.3B. Elevance Health's net income of $1B is higher than Molina Healthcare's net income of $326M. Notably, Elevance Health's price-to-earnings ratio is 13.53x while Molina Healthcare's PE ratio is 14.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.50x versus 0.44x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

Oscar Health has a net margin of 2.25% compared to Elevance Health's net margin of -2.25%. Elevance Health's return on equity of 15.67% beat Oscar Health's return on equity of 2.86%.

Elevance Health has a consensus price target of $505.44, signalling upside risk potential of 36.21%. On the other hand Oscar Health has an analysts' consensus of $19.00 which suggests that it could grow by 36.41%. Given that Oscar Health has higher upside potential than Elevance Health, analysts believe Oscar Health is more attractive than Elevance Health.

Elevance Health has a beta of 0.828, which suggesting that the stock is 17.228% less volatile than S&P 500. In comparison Oscar Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Elevance Health has a quarterly dividend of $1.63 per share corresponding to a yield of 1.76%. Oscar Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 23.3% of its earnings as a dividend. Oscar Health pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health quarterly revenues are $45.1B, which are larger than Oscar Health quarterly revenues of $2.4B. Elevance Health's net income of $1B is higher than Oscar Health's net income of -$54.6M. Notably, Elevance Health's price-to-earnings ratio is 13.53x while Oscar Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.50x versus 0.46x for Oscar Health. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of 2.25% compared to Elevance Health's net margin of 6.11%. Elevance Health's return on equity of 15.67% beat UnitedHealth Group's return on equity of 14.51%.

Elevance Health has a consensus price target of $505.44, signalling upside risk potential of 36.21%. On the other hand UnitedHealth Group has an analysts' consensus of $636.05 which suggests that it could grow by 24.44%. Given that Elevance Health has higher upside potential than UnitedHealth Group, analysts believe Elevance Health is more attractive than UnitedHealth Group.

Elevance Health has a beta of 0.828, which suggesting that the stock is 17.228% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.583, suggesting its less volatile than the S&P 500 by 41.67%.

Elevance Health has a quarterly dividend of $1.63 per share corresponding to a yield of 1.76%. UnitedHealth Group offers a yield of 1.6% to investors and pays a quarterly dividend of $2.10 per share. Elevance Health pays 23.3% of its earnings as a dividend. UnitedHealth Group pays out 30.21% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health quarterly revenues are $45.1B, which are smaller than UnitedHealth Group quarterly revenues of $99.2B. Elevance Health's net income of $1B is lower than UnitedHealth Group's net income of $6.1B. Notably, Elevance Health's price-to-earnings ratio is 13.53x while UnitedHealth Group's PE ratio is 33.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.50x versus 1.22x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.